LENZ Therapeutics Inc.

NASDAQ: LENZ
Share price (12/20/24): $32.63
Market cap (12/20/24): $897 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement

Prospectus supplement

Prospectus supplement

Prospectus supplement

Ownership Filter

Tang Capital Management LLC

Versant Venture Capital VI, L.P.

Ridgeback Capital Investments L.P.

Schimmelpennink Evert B.

News Filter

Reports Third Quarter 2024 Financial Results

CORXEL and LENZ Therapeutics Announce Positive Topline Data From China Phase 3 Presbyopia Trial of LNZ100

Reports Second Quarter 2024 Financial Results

Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia

Announces $30 Million Investment From Ridgeback Capital

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC